| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 12/24/2008 | WO2008106080A3 Synthesis of desacetoxytubulysin h and analogs thereof |
| 12/24/2008 | WO2008012086A3 Protein-binding methotrexate derivatives, and medicaments containing the same |
| 12/24/2008 | WO2008009002A3 Reagents for the detection of protein phosphorylation in signaling pathways |
| 12/24/2008 | EP2004673A1 Immunomodulating oligopeptides |
| 12/24/2008 | EP2004670A1 Process for the manufacture of lysobactin derivatives |
| 12/24/2008 | EP2004600A1 Iap bir domain binding compounds |
| 12/24/2008 | EP2004239A2 Novel integrin binding rgd-lipopeptides with gene transfer activities |
| 12/24/2008 | EP2003967A2 Use of somatostatin agonists to treat medullary thyroid carcinoma |
| 12/24/2008 | EP1181555B1 Cancer treatment with endothelin receptor antagonists |
| 12/24/2008 | CA2727391A1 Azapeptides as cd36 binding compounds |
| 12/24/2008 | CA2690734A1 Polypeptides and methods of use |
| 12/23/2008 | US7468425 p40 protein acts as an oncogene |
| 12/23/2008 | US7468388 Using 5-aceylamino-4-azido-4-nitrophenoxycarbonyloyl) -(2-oxo (1,3-dioxolan-4-yl)-5,6-dihydropyran-2-carxylic acid methyl ester; therapy for myxovirus infections; active materials; stability; long time in lungs |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468354 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery |
| 12/18/2008 | WO2008152306A2 Novel peptidase substrates |
| 12/18/2008 | WO2008152178A1 Cysteine proteases inhibitors |
| 12/18/2008 | WO2008113992A3 Gel compositions comprising urea derivatives |
| 12/18/2008 | WO2008076490A3 Histophilus somni antigens, compositions and methods of use |
| 12/18/2008 | US20080312159 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 12/18/2008 | US20080311079 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 12/18/2008 | US20080311051 Caspase-2 Inhibitors And Their Biological Applications |
| 12/17/2008 | EP2003142A1 Amorphous perindopril erbumine |
| 12/17/2008 | EP2002259A2 Disheveled pdz modulators |
| 12/17/2008 | EP1759212B1 Identification of compounds modifying a cellular response |
| 12/17/2008 | EP0966297B1 Regulation of gastrointestinal motility |
| 12/16/2008 | US7465721 N-(10H-phenothiazin-2-ylcarbonyl)-L-leucyl-L-leucyl-N1-[(3 S)-2-methoxytetrahydrofuran-3-yl]-L-leucinamide; calpain (proteolytic enzyme) inhibitor; traps the reactive oxygen species ; antiinflammatory, antiproliferative agent, autoimmune diseases |
| 12/16/2008 | US7465710 Dipeptides and tripeptides; neuropeptide Y ("NPY") receptor antagonists and agonists |
| 12/16/2008 | US7465705 Immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies; diabetic neuropathy; brain injury, spinal cord injury |
| 12/11/2008 | WO2008151306A1 Synthesis of cyclodepsipeptide compounds having antineoplastic and/or antimicrobial activity |
| 12/11/2008 | WO2008103693A3 Chemical linkers with single amino acids and conjugates thereof |
| 12/11/2008 | WO2008088875A3 Method of treating hepatitis c virus |
| 12/11/2008 | WO2008088385A3 Peptides that enhance acetylcholinesterase expression |
| 12/11/2008 | WO2008057608A8 Synthetic peptide amides |
| 12/11/2008 | US20080306242 Intermediates for lhrh antagonist synthesis, process for the production, and process for lhrh antagonist production |
| 12/11/2008 | US20080305101 Methods and Compositions Related to Clot Binding Compounds |
| 12/10/2008 | EP1998792A2 Methods and compositions related to cyclic peptide synthesis |
| 12/10/2008 | EP1002069B1 Peptides containing the motif igd and their use as cell migration modulators |
| 12/10/2008 | CN101321521A Matrix-controlled transdermal system comprising salts of ACE inhibitor dicarboxylic acids |
| 12/10/2008 | CN101318992A Complete-basic amino acid oligopeptide, copper complex, synthesis method, self-assembly and application thereof |
| 12/10/2008 | CN100441594C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 12/10/2008 | CN100441220C Composition containing dipeptide of histidine and alanine for reducing uric acid |
| 12/09/2008 | US7462746 Amino polyols and amino sugars |
| 12/09/2008 | US7462690 form a carboxyl-terminal amide of a desired peptide comprising contacting a substrate polypeptide and a palladium complex, where the palladium complex is a palladium(II) or palladium(IV) complex |
| 12/09/2008 | US7462599 Use of effectors of glutaminyl and glutamate cyclases |
| 12/09/2008 | US7462486 Monitoring the efficacy of a T Cell Receptor (TCR) Variable peptide for the treatment of autoimmune diseases such as multiple sclerosis, Rheumatoid arthritis, systemic lupus erythematosis, type I diabetes, non-obese diabetes, psoriasis |
| 12/09/2008 | US7462462 Peptide capable of binding to nanographite structures |
| 12/09/2008 | CA2415447C Novel .gamma. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 12/04/2008 | WO2007114959A3 Altered peptide ligands of gad65 |
| 12/04/2008 | WO2007112410A3 Tolerizing agents |
| 12/04/2008 | US20080300382 Immunogenic Complexes, Preparation Method Thereof And Use Of Same In Pharmaceutical Compositions |
| 12/04/2008 | US20080300220 Linkable Lewis X Analogs |
| 12/04/2008 | US20080300192 Auristatins Having an Aminobenzoic Acid Unit at the N Terminus |
| 12/04/2008 | US20080300191 Cbz-Leu-Gln-fluoromethyl ketone; 4-(Cbz-Val-Leu-amido)-6-fluoro-5-oxo-hexanoic acid dimethylamide; 4-(Cbz-Leu-amido)-6-Fluoro-5-oxo-hexanoic acid methylamide; 4-(Cbz-Ile-amido)-6-fluoro-5-oxo-hexanoic acid methylamide; 4-(Cbz-Val-amido)-6-fluoro-5-oxo-hexanoic acid methylamide |
| 12/04/2008 | US20080300180 Growth Hormone Secretagogue Receptor 1A Ligands |
| 12/04/2008 | US20080299596 Substrates and assays for beta-secretase activity |
| 12/04/2008 | US20080299180 Peptides based on the sequence of human lactoferrin and their use |
| 12/03/2008 | EP1997828A2 Stabilized alpha helical peptides from BCL-2 and uses thereof |
| 12/03/2008 | EP1997826A2 Synthetic ligands for immunoglobulins and pharmaceutical compositions containing them |
| 12/03/2008 | EP1997823A1 Boronic ester and acid compounds, synthesis and uses |
| 12/03/2008 | EP1996608A1 Cyclopeptide with anti-cancer activity derived from collagen type iv |
| 12/03/2008 | EP1996606A1 Tropolone- and hydroxybenzene-substituted oligopeptides for depigmentation |
| 12/03/2008 | EP1711514B1 Method of removing transition metals from reaction solutions comprising transition metal byproducts |
| 12/03/2008 | EP1006122B1 Phenethylamine derivatives |
| 12/03/2008 | CN101316852A Inhibitors of serine proteases |
| 12/03/2008 | CN100439393C Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 12/03/2008 | CN100439392C Novel method for the synthesis of perinidopril and the pharmaceutically acceptable salts thereof |
| 12/02/2008 | US7459533 Interleukin-10 homolog for use as a therapeutic tool in treatment and prevention of inflammatory, autoimmue and cell proliferative disorders |
| 12/02/2008 | US7459529 AIMP2-DX2 and its uses |
| 12/02/2008 | CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 11/27/2008 | WO2008144747A2 Lipoproteins, lipopeptides and analogs, and methods for making and using them |
| 11/27/2008 | WO2008144675A1 Crystalline and amorphous forms of peptide |
| 11/27/2008 | WO2008142319A2 Peptide analogues of melanocortin receptors |
| 11/27/2008 | WO2008006087A3 Antibodies to conformationally trapped proteins |
| 11/27/2008 | US20080293962 Novel compounds of the N-acylamino amide family compositions comprising them and uses thereof |
| 11/27/2008 | US20080293921 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue |
| 11/27/2008 | US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses |
| 11/27/2008 | US20080293641 Biologically active peptides |
| 11/27/2008 | US20080292548 Compounds and methods for 18f labeled agents |
| 11/27/2008 | CA2683288A1 Crystalline and amorphous forms of peptide |
| 11/26/2008 | EP1588173B1 Affinity fishing for ligands and proteins receptors |
| 11/26/2008 | EP1578777B1 Iap binding compounds |
| 11/26/2008 | EP0735893B1 Pan dr-binding peptides for enhancement of the immune response |
| 11/26/2008 | CN101313223A Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-l-yl methylene or a pyrimidin-2-yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group |
| 11/26/2008 | CN101312748A 抗体-药物轭合物和使用方法 Antibodies - drug conjugates and methods of use |
| 11/26/2008 | CN101311151A Process for the preparation of 3,3-dimethylbutanal |
| 11/25/2008 | US7456253 Growth hormone releasing peptides |
| 11/25/2008 | US7456251 HIV fusion inhibitor peptides with improved biological properties |
| 11/25/2008 | US7456153 Comprise at least a tryptophan-containing cell adhesion recognition sequence; cancer modulating agent |
| 11/20/2008 | WO2008141012A2 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof |
| 11/20/2008 | WO2008141010A2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 11/20/2008 | WO2008140782A2 Compounds for enzyme inhibition |
| 11/20/2008 | WO2008139947A1 Prophylactic or therapeutic agent for diarrhea |
| 11/20/2008 | WO2008138620A2 1-aminocyclopentane-1,3,4-tricarboxylic acids derivatives |
| 11/20/2008 | WO2008138561A1 Tubulysine derivatives |
| 11/20/2008 | WO2008138495A1 Method for purifying brush border membrane (bbm) proteins |
| 11/20/2008 | WO2008098693A3 Convergent synthesis of glp-1 |
| 11/20/2008 | WO2008085828A3 Peptide modulators of angiogenesis and use thereof |
| 11/20/2008 | US20080287649 Methods for the synthesis of cyclic peptides |
| 11/20/2008 | US20080287370 Boronic Acid Salts Useful in Parenteral Formulations |